Insider · CIK 0001231291

THOMAS MCNERNEY & PARTNERS LP

Reports to the SEC for 5 companies · MINNEAPOLIS, MN

sec.gov

Transactions

Companies

Filings

CIK

0001231291

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-04-20	Clarus Therapeutics Holdings, Inc.S Sale	10% Owner	SSale	−1.66M sh	$2.53	−$4.21M	773,599
2022-04-20	CLARUS THERAPEUTICS INCS Sale	10% Owner	SSale	−1,164 sh	$2.53	−$2,944.92	542
2022-04-20	CLARUS THERAPEUTICS INCS Sale	10% Owner	SSale	−13.6K sh	$2.53	−$34.5K	6,340
2022-04-20	CLARUS THERAPEUTICS INCS Sale	10% Owner	SSale	−5,722 sh	$2.53	−$14.5K	2,661
2022-04-20	CLARUS THERAPEUTICS INCS Sale	10% Owner	SSale	−1.66M sh	$2.53	−$4.21M	773,599
2022-04-20	Clarus Therapeutics Holdings, Inc.S Sale	10% Owner	SSale	−5,722 sh	$2.53	−$14.5K	2,661
2022-04-20	Clarus Therapeutics Holdings, Inc.S Sale	10% Owner	SSale	−2.06M sh	$2.53	−$5.22M	958,989
2022-04-20	CLARUS THERAPEUTICS INCS Sale	10% Owner	SSale	−7,585 sh	$2.53	−$19.2K	3,528
2022-04-20	CLARUS THERAPEUTICS INCS Sale	10% Owner	SSale	−2.06M sh	$2.53	−$5.22M	958,989
2022-04-20	Clarus Therapeutics Holdings, Inc.S Sale	10% Owner	SSale	−7,585 sh	$2.53	−$19.2K	3,528
2022-04-20	Clarus Therapeutics Holdings, Inc.S Sale	10% Owner	SSale	−1,164 sh	$2.53	−$2,944.92	542
2022-04-20	Clarus Therapeutics Holdings, Inc.S Sale	10% Owner	SSale	−13.6K sh	$2.53	−$34.5K	6,340
2013-07-15	Ocera Therapeutics, Inc.J Other	10% Owner	JOther	+763K sh	$6.00	+$4.58M	762,892
2013-07-15	Ocera Therapeutics, Inc.J Other	10% Owner	JOther	+1.68M sh	$6.00	+$10.1M	1,675,677
2012-10-01	Ocera Therapeutics, Inc.WarrantsA Award	10% Owner	AAward	+162K sh	$44.23	+$7.16M	161,855
2012-08-07	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	10% Owner	AAward	+31.8K sh	—	—	31,835
2012-03-30	Ocera Therapeutics, Inc.WarrantsA Award	10% Owner	AAward	+162K sh	$44.23	+$7.16M	161,855
2011-04-19	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	10% Owner	AAward	+25K sh	—	—	25,000
2011-04-06	Ocera Therapeutics, Inc.Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−14.7M sh	—	—	0
2011-04-06	Ocera Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+2,966 sh	$4.00	+$11.9K	3,002,286
2011-04-06	Ocera Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+14.6K sh	$4.00	+$58.3K	2,999,320
2011-04-06	Ocera Therapeutics, Inc.Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−55.9K sh	—	—	0
2011-04-06	Ocera Therapeutics, Inc.C Conversion	10% Owner	CConversion	+7,988 sh	—	—	2,189,786
2011-04-06	Ocera Therapeutics, Inc.C Conversion	10% Owner	CConversion	+78.2K sh	—	—	2,181,798
2011-04-06	Ocera Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.1M sh	—	—	2,103,623
2011-04-06	Ocera Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+795K sh	$4.00	+$3.18M	2,984,752
2011-04-06	Ocera Therapeutics, Inc.Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−547K sh	—	—	0
2010-11-29	ZOGENIX, INC.P Purchase	See Footnote (10)	PPurchase	+5,476 sh	$4.00	+$21.9K	14,700
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+1,840 sh	—	—	1,840
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+1,473 sh	—	—	3,313
2010-11-29	ZOGENIX, INC.P Purchase	See Footnote (10)	PPurchase	+1,967 sh	$4.00	+$7,868	5,280
2010-11-29	ZOGENIX, INC.Series B Convertible Preferred StockC Conversion	See Footnote (10)	CConversion	−4.91M sh	—	—	0
2010-11-29	ZOGENIX, INC.8% Convertible Promissory NoteC Conversion	See Footnote (10)	CConversion	−393K sh	—	—	0
2010-11-29	ZOGENIX, INC.Series B Convertible Preferred StockC Conversion	See Footnote (10)	CConversion	−51.2K sh	—	—	0
2010-11-29	ZOGENIX, INC.Series B Convertible Preferred StockC Conversion	See Footnote (10)	CConversion	−18.4K sh	—	—	0
2010-11-29	ZOGENIX, INC.8% Convertible Promissory NoteC Conversion	See Footnote (10)	CConversion	−1,473 sh	—	—	0
2010-11-29	ZOGENIX, INC.8% Convertible Promissory NoteC Conversion	See Footnote (10)	CConversion	−4,101 sh	—	—	0
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+1.15M sh	—	—	1,152,780
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+207K sh	—	—	1,359,939
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+130K sh	—	—	1,489,794
2010-11-29	ZOGENIX, INC.P Purchase	See Footnote (10)	PPurchase	+173K sh	$4.00	+$694K	1,663,193
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+42.8K sh	—	—	42,840
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+7,697 sh	—	—	50,537
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+2,379 sh	—	—	52,916
2010-11-29	ZOGENIX, INC.P Purchase	See Footnote (10)	PPurchase	+3,178 sh	$4.00	+$12.7K	56,094
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+4,380 sh	—	—	4,380
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+786 sh	—	—	5,166
2010-11-29	ZOGENIX, INC.C Conversion	See Footnote (10)	CConversion	+484 sh	—	—	5,650
2010-11-29	ZOGENIX, INC.P Purchase	See Footnote (10)	PPurchase	+647 sh	$4.00	+$2,588	6,297
2010-11-29	ZOGENIX, INC.Series A-1 Convertible Preferred StockC Conversion	See Footnote (10)	CConversion	−11.5M sh	—	—	0

Recent filings

Accepted (ET)
Apr 254/A
THOMAS JAMES E0001062993-22-010736
SEC(opens sec.gov)
Apr 214
THOMAS JAMES E0001062993-22-010622
SEC(opens sec.gov)
Jul 174/A
Ocera Therapeutics, Inc.0001144204-13-040001
SEC(opens sec.gov)

Companies

Address

60 SOUTH 6TH STREET SUITE 3620

MINNEAPOLIS, MN, 55402